Primary squamous carcinoma of breast - a rare entity: report of two cases and review of the literature.

Pathology

Tissue Pathology and Diagnostic Oncology, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia; Sydney University Medical School, Sydney, NSW, Australia.

Published: August 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2019.03.003DOI Listing

Publication Analysis

Top Keywords

primary squamous
4
squamous carcinoma
4
carcinoma breast
4
breast rare
4
rare entity
4
entity report
4
report cases
4
cases review
4
review literature
4
primary
1

Similar Publications

Objective: The objective of this study was to evaluate the Pap smear and colposcopy findings in female inmates in a prison unit in the state of São Paulo, Brazil.

Methods: A retrospective cross-sectional study was carried out by analyzing the Pap smear and colposcopy examinations of female inmates in a prison unit. The following socio-demographic data were assessed: age, nationality, level of education, marital status, height, weight, ethnicity, occupation, religion, sexual orientation, and presence of tattoos.

View Article and Find Full Text PDF

Background: Primary pulmonary lymphoepithelial carcinoma (PPLEC) is a rare form of lung malignancy, accounting for only 0.7% of all lung cancers. It is currently classified as a distinct subtype within squamous cell carcinomas.

View Article and Find Full Text PDF

TP53 genetic heterogeneity in recurrent or second primary head and neck squamous cell carcinoma.

Radiother Oncol

January 2025

The Head and Neck Cancer Research Laboratory, Tel Aviv, Israel; The Department of Otolaryngology, Head and Neck Surgery and Maxillofacial Surgery, Tel Aviv, Israel. Electronic address:

Head and neck squamous cell carcinomas (HNSCC) frequently recur, and patients often develop second primary tumors. Their distinction is clinically challenging. TP53 mutational heterogeneity may indicate novel molecular events rather than resistant clones' expansion or persistent disease.

View Article and Find Full Text PDF

Background: Dermatomyositis is a chronic autoimmune disease with distinctive cutaneous eruptions and muscle weakness, and the pathophysiology is characterised by type I interferon (IFN) dysregulation. This study aims to assess the efficacy, safety, and target engagement of dazukibart, a potent, selective, humanised IgG1 neutralising monoclonal antibody directed against IFNβ, in adults with moderate-to-severe dermatomyositis.

Methods: This multicentre, double-blind, randomised, placebo-controlled, phase 2 trial was conducted at 25 university-based hospitals and outpatient sites in Germany, Hungary, Poland, Spain, and the USA.

View Article and Find Full Text PDF

PD-L1-Expression in in primary and recurrent vulvar squamous cell cancer.

Gynecol Oncol

January 2025

Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich-Alexander-Universität Erlangen-Nürnberg, Krankenhausstrasse 8-10, 91054 Erlangen, Germany.

Background: Squamous cell vulvar carcinoma is a rare malignant disease of women. In higher tumor stages survival rates are poor. Therapy options are limited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!